BSE is offering a new system for Ambient units. This is a proven patented technology that delivers clean indoor air that is safe and healthy.
Ambient Air Cleaners now have an option to add NPBI technology. These ionizers can be installed at the factory as an option on the “clean air side” of any of HEPA filtered ambient units. The filters in our units will continue to provide “active” filtration of the dirty air passing through them, while the ionizer projects ions via the exhaust air to provide “passive” air filtration outside of the unit. The ions produced travel within the air stream into the occupied spaces, cleaning the air everywhere the ions travel, even in spaces unseen.
The Needlepoint Bipolar Ionization (NPBI) technology is UL approved.
How it works
The NPBI technology works to safely clean the air inside your building. The patented technology uses an electronic charge to create a plasma field filled with a high concentration of + and – ions that replicate those commonly found in nature. As these ions travel with the air stream they attach to particles, pathogens and gases/odors. As the ions attach to airborne particles (including fine, sub-micron particles) they are then attracted to each other, making the particulate more easily filterable and increasing capture efficiency. The ions kill pathogens by robbing them of life-sustaining hydrogen. The ions breakdown harmful gases/odors into harmless compounds like O2, CO2, N2 and H2O.
Pathogen awareness and mitigation have become the highest of priorities as it relates to our personal safety and that of our customers and their employees. New third party testing confirms that NBPI’s effectiveness is a solution that we can offer in the struggle against COVID-19:
What type of virus is COVID-19?
Viruses can be generally categorized in three groups by virus structure:
- Enveloped viruses - Easiest to kill
- Examples: Influenza A and Coronaviruses
- Large, non-enveloped viruses - More difficult to kill
- Small, non-enveloped viruses - Hardest to kill
- Examples: Norovirus and Rhinovir
How does this relate to our new NBPI offering?
- The patented NPBI technology being utilized in our Ambient units now have a documented kill rate on virus of COVID-19 of 99.4%.
- NBPI testing further suggests the technologies effectiveness in a “hierarchy based” solution to future and pending threats.
3rd Party Testing
Tuberculosis |
69.09% |
EMSL |
Legionella |
99.71% |
EMSL |
Clostridium Difficile (C. Diff.) |
86.87% |
EMSL |
Norovirus |
93.50% |
ATS Labs |
MRSA |
96.24% |
EMSL |
Staphylococcus |
96.24% |
EMSL |
Mold Spores |
99.50% |
GCA |
Escherichia coli (E.Coli) |
99.69% |
EMSL |
Coronavirus (COVID-19) |
99.40% |
EMSL |
Notable Users of NPBI Technology
- Boston Children’s Hospital
- Mayo Clinic
- The White House
- Clemson University
- Harvard University
- Charlotte Airport
- Baylor UMC
- Houston Memorial Hospital